Core Competitors
| CLB Stock | USD 19.59 0.05 0.26% |
Core Laboratories vs Highpeak Energy Correlation
Pay attention - limited upside
The correlation between Core Laboratories NV and HPK is -0.71 (i.e., Pay attention - limited upside) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Core Laboratories NV and HPK in the same portfolio, assuming nothing else is changed.
Moving together with Core Stock
| 0.73 | VTOL | Bristow Group | PairCorr |
| 0.65 | AT | Ashtead Technology | PairCorr |
| 0.89 | RES | RPC Inc | PairCorr |
| 0.92 | NESR | National Energy Services | PairCorr |
| 0.79 | NPKI | NPK International Earnings Call This Week | PairCorr |
Moving against Core Stock
| 0.81 | PBCRY | Bank Central Asia | PairCorr |
| 0.62 | ENSV | Enservco | PairCorr |
| 0.59 | PTAIF | PT Astra International | PairCorr |
| 0.32 | BKRKF | PT Bank Rakyat | PairCorr |
Core Laboratories Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Core Laboratories and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Core and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Core Laboratories does not affect the price movement of the other competitor.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Core Stock performing well and Core Laboratories Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Core Laboratories' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| CAPL | 0.82 | 0.15 | 0.09 | 3.48 | 0.90 | 1.86 | 4.94 | |||
| BORR | 2.27 | 0.69 | 0.22 | 0.76 | 2.35 | 5.94 | 15.66 | |||
| TNP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| PDS | 1.49 | 0.45 | 0.27 | 0.84 | 1.29 | 3.27 | 7.53 | |||
| GRNT | 1.85 | (0.04) | 0.00 | (0.04) | 0.00 | 3.44 | 8.29 | |||
| NBR | 2.51 | 0.52 | 0.17 | 0.54 | 2.52 | 8.06 | 17.59 | |||
| VTS | 1.26 | (0.03) | 0.00 | 0.40 | 0.00 | 2.80 | 6.95 | |||
| TXO | 1.29 | (0.10) | 0.00 | (5.96) | 0.00 | 2.35 | 6.59 | |||
| SOC | 9.03 | 0.05 | 0.02 | 0.06 | 10.95 | 20.50 | 72.14 | |||
| HPK | 3.99 | (0.37) | 0.00 | (0.55) | 0.00 | 8.28 | 21.96 |
Cross Equities Net Income Analysis
Compare Core Laboratories and related stocks such as Crossamerica Partners, Borr Drilling, and Tsakos Energy Navigation Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CAPL | (5 M) | 9.9 M | (3.6 M) | 18.1 M | (6.2 M) | 11.4 M | 10.7 M | 23.2 M | 5.3 M | 18.1 M | 107.5 M | 21.7 M | 62 M | 40.1 M | 19.9 M | 22.9 M | 24.4 M |
| BORR | (755 K) | (755 K) | (755 K) | (755 K) | (755 K) | (755 K) | (755 K) | (88 M) | (190.5 M) | (297.6 M) | (317.6 M) | (193 M) | (292.8 M) | 22.1 M | 82.1 M | 94.4 M | 99.1 M |
| PDS | 17.6 M | 193.5 M | 52.4 M | 191.2 M | 33.2 M | (363.4 M) | (155.6 M) | (132 M) | (294.3 M) | 6.6 M | (94.3 M) | (177.4 M) | (34.3 M) | 289.2 M | 111.2 M | 100.1 M | 103.2 M |
| GRNT | 3.6 M | 3.6 M | 3.6 M | 3.6 M | 3.6 M | 3.6 M | 3.6 M | 3.6 M | 3.6 M | 3.6 M | (23.9 M) | 108.5 M | 262.3 M | 81.1 M | 18.8 M | 21.6 M | 20.5 M |
| NBR | (22.8 M) | 243.7 M | 232.4 M | 149.9 M | (670.7 M) | (372.7 M) | (1 B) | (546.8 M) | (640.9 M) | (723.9 M) | (805.6 M) | (569.3 M) | (350.3 M) | (11.8 M) | (176.1 M) | (158.5 M) | (150.6 M) |
| VTS | 35.9 M | 35.9 M | 35.9 M | 35.9 M | 35.9 M | 35.9 M | 35.9 M | 35.9 M | 35.9 M | 35.9 M | (8.9 M) | 18.1 M | 118.9 M | (21.6 M) | 21.1 M | 19 M | 21.8 M |
| SOC | (1.7 K) | (1.7 K) | (1.7 K) | (1.7 K) | (1.7 K) | (1.7 K) | (1.7 K) | (1.7 K) | (1.7 K) | (1.7 K) | 4.3 M | (2.6 M) | (93.7 M) | (629.1 M) | (629.1 M) | (566.2 M) | (537.9 M) |
| HPK | (11.6 M) | (11.6 M) | (11.6 M) | (11.6 M) | (11.6 M) | (11.6 M) | (11.6 M) | (11.6 M) | (11.6 M) | (11.6 M) | (101.5 M) | 55.6 M | 236.9 M | 215.9 M | 95.1 M | 109.3 M | 89.9 M |
Core Laboratories and related stocks such as Crossamerica Partners, Borr Drilling, and Tsakos Energy Navigation Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Core Laboratories financial statement analysis. It represents the amount of money remaining after all of Core Laboratories NV operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Core Laboratories Competitive Analysis
The better you understand Core Laboratories competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Core Laboratories' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Core Laboratories' competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Core Laboratories Competition Performance Charts
Five steps to successful analysis of Core Laboratories Competition
Core Laboratories' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Core Laboratories in relation to its competition. Core Laboratories' competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Core Laboratories in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Core Laboratories' competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Core Laboratories, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Core Laboratories position
In addition to having Core Laboratories in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Drugs Thematic Idea Now
Drugs
Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. The Drugs theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Drugs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Core Laboratories Correlation with its peers. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Oil & Gas Equipment & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Core Laboratories. Projected growth potential of Core fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Core Laboratories assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth 0.2 | Dividend Share 0.04 | Earnings Share 0.68 | Revenue Per Share | Quarterly Revenue Growth 0.001 |
The market value of Core Laboratories is measured differently than its book value, which is the value of Core that is recorded on the company's balance sheet. Investors also form their own opinion of Core Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Core Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Core Laboratories' market value can be influenced by many factors that don't directly affect Core Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Core Laboratories' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Core Laboratories should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Core Laboratories' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.